Dosage form design for improvement of bioavailability of levodopa IV: Possible causes of low bioavailability of oral levodopa in dogs
- 1 July 1981
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 70 (7) , 730-733
- https://doi.org/10.1002/jps.2600700705
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Dosage form design for improvement of bioavailability of levodopa III: Influence of dose on pharmacokinetic behavior of levodopa in dogs and parkinsonian patientsJournal of Pharmaceutical Sciences, 1980
- Dosage form Design for Improvement of Bioavailability of Levodopa II: Bioavailability of Marketed Levodopa Preparations in Dogs and Parkinsonian PatientsJournal of Pharmaceutical Sciences, 1980
- Influence of route of administration on physiological availability of levodopa in dogsJournal of Pharmaceutical Sciences, 1976
- The role of the liver in the clearance ofl-dopa from plasmaJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Metabolism of drugs by microorganisms in the intestineThe American Journal of Clinical Nutrition, 1974
- Urinary Phenolic Compounds in Gnotobiotic and Conventional Rats on a Free Diet, and Before and after L‐DOPA Loading on a Milk Diet*Acta Pharmacologica et Toxicologica, 1971
- Minor Urinary Metabolites of L‐Dopa in the RatActa Pharmacologica et Toxicologica, 1971